The partnership brings together Pfizer’s scientific data and therapeutic expertise with Boltz’s open-source AI foundation ...

A hidden enzyme developed by big pharma has taken over the dairy industry, sparking a nationwide boycott as consumers demand ...

Pfizer Inc. will spend $470 million to expand its vaccine research facilities 25 miles northwest of New York City, where the company hopes to maintain its edge in the booming field of messenger RNA, ...

Pfizer said Wednesday that a booster of its COVID-19 vaccine may offer important protection against the new omicron variant even though the initial two doses appear significantly less effective.

TOKYO, Sept 21 (Reuters) - Pfizer Inc , the world's largest drug maker, said on Friday it is in talks with investors about spinning off its Japanese research and development laboratory, albeit as a ...

NEW YORK - Pfizer said Wednesday that a booster dose of its COVID-19 vaccine may protect against the new omicron variant even though the initial two doses appear significantly less effective. Pfizer ...

The Pfizer-BioNTech Covid-19 vaccine appears to be less effective against the heavily mutated omicron variant of the coronavirus, according to early data from South Africa posted Tuesday. Researchers ...